Specific Inhibition of the VEGFR-3 Tyrosine Kinase by SAR131675 Reduces Peripheral and Tumor Associated Immunosuppressive Myeloid Cells

Cancers - Switzerland
doi 10.3390/cancers6010472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, Against VEGFR-1 and Members of the Structurally Related PDGFR Family

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Synergistic Inhibition of Head and Neck Tumor Growth by Green Tea (−)‐epigallocatechin‐3‐gallate and EGFR Tyrosine Kinase Inhibitor

International Journal of Cancer
Cancer ResearchOncology
2008English

Immunosuppressive Activity of Tumor-Infiltrating Myeloid Cells in Patients With Meningioma

OncoImmunology
OncologyAllergyImmunology
2018English

Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth

Clinical Cancer Research
Cancer ResearchOncology
2019English

Selective LRRK2 Kinase Inhibition Reduces Phosphorylation of Endogenous Rab10 and Rab12 in Human Peripheral Mononuclear Blood Cells

Scientific Reports
Multidisciplinary
2017English

Inhibition of BCR Serine Kinase by Tyrosine Phosphorylation.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1996English

Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model

Haematologica
Hematology
2019English

Tyrosine Kinase Inhibition: A Therapeutic Target for the Management of Chronic-Phase Chronic Myeloid Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy